Last reviewed · How we verify

NCT05517863: wounds

The Effect of Combined 650 nm and Infrared Laser on Chronic Diabetic Foot Ulcer Surface Area:

Completed NA Last updated 23 October 2023
What this trial tests

NA trial testing laser therapy in Diabetic Foot in 45 participants. Completed in 27 July 2022.

Timeline
1 March 2022
Primary endpoint
12 July 2022
27 July 2022

Quick facts

Lead sponsorHeidy F. Ahmed
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment45
Start date1 March 2022
Primary completion12 July 2022
Estimated completion27 July 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Heidy F. Ahmed

Who can join

Adults 20 to 60, any sex, with Diabetic Foot or Wound Heal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: investigate the effect of combined 650 nm and infrared laser on chronic diabetic foot ulcer surface area. Participants: The forty five patients will assigned randomly into three equal groups, each group consist of 15 patients, group A received laser therapy in sequential mode, group B received laser therapy in separate mode and the control group C receive traditional wound care

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Advances in nucleic acid delivery strategies for diabetic wound therapy.
    Sarthi S, Bhardwaj H, Kumar Jangde R. · · 2024 · cited 4× · PMID 39286540 · DOI 10.1016/j.jcte.2024.100366

Verify or expand the search:

Other trials of laser therapy

Trials testing the same drug.

Other recruiting trials for Diabetic Foot

Currently open trials in the same condition.

Other Heidy F. Ahmed trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05517863.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing